Alnylam Pharmaceuticals Inc (ALNY)

237.97 -4.53 (-1.87%) USD  |  NASDAQ  |  Dec 27, 16:00
237.94 -0.03 (-0.01%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Cash and Short Term Investments (Annual): 2.439B for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Pfizer Inc 12.69B
BridgeBio Pharma Inc 434.88M
Gilead Sciences Inc 7.264B
Sarepta Therapeutics Inc 1.676B
Regeneron Pharmaceuticals Inc 10.84B